A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)

NCT04830800 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Disease
SARS Pneumonia
Pneumonia, Viral
COVID-19 Vaccine

Interventions

BIOLOGICAL: COVIVAC
BIOLOGICAL: Phosphate-buffered saline

Sponsor

Institute of Vaccines and Medical Biologicals, Vietnam

Collaborators

[object Object]
[object Object]